|
2024
|
P/S
|
Pharmaceutical and biological preparations for human use. |
|
|
P/S
|
Pharmaceutical and biological preparations for human use. |
|
|
P/S
|
Pharmaceutical and biological preparations for human use. |
|
|
P/S
|
Pharmaceutical preparations for human use for the treatment of cancer. Providing medical and scie... |
|
|
P/S
|
Pharmaceutical research and development relating to pharmaceutical preparations for human use. |
|
2023
|
Invention
|
Substituted heterocyclic compounds.
There are disclosed compounds of the following formula I:
... |
|
|
P/S
|
Marketing research; development of marketing strategies and concepts; concept and brand developme... |
|
|
Invention
|
System for verifying accuracy of serially-connected drug modules in a combinatorial drug delivery... |
|
|
Invention
|
Combination therapy using an anti-fucosyl-gm1 antibody and an anti-cd137 antibody.
This disclosu... |
|
|
Invention
|
Method of purifying proteins.
In some embodiments, the present invention provides a method of pu... |
|
|
Invention
|
Methods of treating urothelial carcinoma using an anti-pd-1 antibody.
This disclosure provides a... |
|
|
Invention
|
Treatment and detection methods for inflammatory bowel disease.
The present disclosure provides ... |
|
|
Invention
|
Process for the preparation of tert-butyl (2-azabicyclo[2.2.1]heptan-4-yl)carbamate and related c... |
|
|
Invention
|
Novel phosphorous (v)-based reagents, processes for the preparation thereof, and their use in mak... |
|
|
Invention
|
Method of treating advanced hepatic fibrosis associated with hcv infection with targeted lipid na... |
|
|
Invention
|
Tim-3 antagonists for the treatment and diagnosis of cancers.
Provided herein are methods for tr... |
|
|
Invention
|
Macrocyclic immunomodulators. in vitroin vitro immunomodulatory efficacy thus making them therape... |
|
|
Invention
|
Methods of separating chelator. The present disclosure is directed to methods of separating a che... |
|
|
Invention
|
Kras g12d inhibitors. The present disclosure relates to KRAS inhibitors. Methods of treating canc... |
|
|
Invention
|
Supramolecular filamentous assemblies for protein purification.
The present invention provide no... |
|
|
Invention
|
Anti-ror1 macrocyclic peptides and compositions.
There are disclosed novel anti-ROR1 macrocyclic... |
|
|
Invention
|
Antagonistic cd40 monoclonal antibodies and uses thereof.
The disclosure provides for antibodies... |
|
|
Invention
|
Treatment of lag-3 positive tumors.
The invention provides a method of treating a tumor in a hum... |
|
|
Invention
|
Kras inhibitors. The present disclosure provides KRAS inhibitors. Methods of treating cancers usi... |
|
|
Invention
|
Method of treating lung cancer.
This disclosure provides a method for treating a subject afflict... |
|
|
Invention
|
Substituted tetrazolyl compounds useful as t cell activators. 1233, and n are defined herein. Als... |
|
|
Invention
|
Tertiary amine substituted bicyclic compounds useful as t cell activators. 12456 6 are defined he... |
|
|
Invention
|
Method of treating cancer using immune checkpoint inhibitor.
This disclosure provides a method f... |
|
|
Invention
|
Antibodies binding to human pad4 and uses thereof.
The present application relates to particular... |
|
|
Invention
|
Heteroaryl compounds as ligand directed degraders of irak4.
Provided herein are compounds and co... |
|
|
Invention
|
Triazolopyridinyl compounds as kinase inhibitors.
Compounds having formula (I), and enantiomers,... |
|
|
Invention
|
Wee1 degrading compounds and uses thereof.
Provided herein are compounds and compositions thereo... |
|
|
Invention
|
Compositions comprising an anti-lag-3 antibody or an anti-lag-3 antibody and an anti-pd-1 or anti... |
|
|
Invention
|
Kras inhibitors.
The present disclosure provides KRAS inhibitors. Methods of treating cancers us... |
|
|
Invention
|
Anti-tl1a antibodies and methods of use thereof.
The present invention discloses an isolated ant... |
|
|
Invention
|
Compositions comprising a combination of an anti-pd-1 antibody and another antibody.
This provid... |
|
|
Invention
|
Antibodies binding to vista at acidic ph.
The present application relates to antibodies specific... |
|
2022
|
Invention
|
Non-chromatographic purification of macrocyclic peptides by a resin catch and release.
The discl... |
|
|
Invention
|
Patient response-based biomarker topology quantification and assessment for multiple tissue types... |
|
|
Invention
|
Benzofuran compounds as sting agonists.
The present invention is directed to compounds of formul... |
|
|
Invention
|
Combination therapy with anti-pvrig antibodies formulations and anti-pd-1 antibodies.
The presen... |
|
|
Invention
|
[1,2,4]triazolo[1,5-a]pyridinyl substituted indole compounds. Disclosed are compounds of Formula ... |
|
|
Invention
|
Combination therapy using an anti-fucosyl-gm1 antibody.
This disclosure provides combination the... |
|
2021
|
Invention
|
Ligand binding assay using modified retinol binding protein.
The disclosure provides a method of... |
|
|
Invention
|
Methods of treating liver diseases.
The present disclosure provides a method of treating or prev... |
|
|
Invention
|
Lag-3 antagonist therapy for lung cancer.
The disclosure provides a method of treating a human s... |
|
|
Invention
|
Imidazo[1,2-a]pyridine and [1,2,4]triazolo[1,5-a]pyridine derivatives as tlr9 inhibitors for the ... |
|
|
Invention
|
Anti-bcma therapy in autoimmune disorders.
The present invention relates to the treatment or man... |
|
2020
|
Invention
|
Automated parallel autosampler system and method for drawing chromatography samples.
In one aspe... |
|
|
Invention
|
Substituted carbazole compounds.
Disclosed are compounds of Formula (I) or salts thereof, wherei... |
|
|
Invention
|
Compounds useful as immunomodulators.
The present disclosure generally relates to compounds usef... |
|
|
Invention
|
Substituted bicyclic heteroaryl compounds.
Disclosed are compounds of Formula (I) N-oxides, or s... |
|
|
Invention
|
Pharmaceutical formulations of indoleamine 2, 3-dioxygenase inhibitors.
The present application ... |
